Cargando…

A novel eye-movement impairment in multiple sclerosis indicating widespread cortical damage

In multiple sclerosis, remyelination trials have yet to deliver success like that achieved for relapse rates with disease course modifying treatment trials. The challenge is to have a clinical, functional outcome measure. Currently, there are none that have been validated, other than visual evoked p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nij Bijvank, Jenny A, Hof, Sam N, Prouskas, Stefanos E, Schoonheim, Menno M, Uitdehaag, Bernard M J, van Rijn, Laurentius J, Petzold, Axel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232247/ https://www.ncbi.nlm.nih.gov/pubmed/36535900 http://dx.doi.org/10.1093/brain/awac474

Ejemplares similares

Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics
por: Nij Bijvank, Jenny, et al.
Publicado: (2022)

A model for interrogating the clinico‐radiological paradox in multiple sclerosis: Internuclear ophthalmoplegia
por: Nij Bijvank, Jenny A., et al.
Publicado: (2021)

A standardized protocol for quantification of saccadic eye movements: DEMoNS
por: Nij Bijvank, J. A., et al.
Publicado: (2018)

Impaired saccadic eye movements in multiple sclerosis are related to altered functional connectivity of the oculomotor brain network
por: Nij Bijvank, J.A., et al.
Publicado: (2021)

Retinal atrophy in relation to visual functioning and vision-related quality of life in patients with multiple sclerosis
por: Balk, Lisanne J, et al.
Publicado: (2017)

Diagnosing and quantifying a common deficit in multiple sclerosis: Internuclear ophthalmoplegia
por: Nij Bijvank, J.A., et al.
Publicado: (2019)

Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double‐blind, placebo‐controlled cross‐over trial
por: Kanhai, Kawita M. S., et al.
Publicado: (2019)

Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers
por: Coric, Danko, et al.
Publicado: (2017)

The Pulfrich Phenomenon: Practical Implications of the Assessment of Cases and Effectiveness of Treatment
por: Farr, Jane, et al.
Publicado: (2018)

A randomized trial predicting response to cognitive rehabilitation in multiple sclerosis: Is there a window of opportunity?
por: Prouskas, Stefanos E, et al.
Publicado: (2022)

4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes
por: Strijbis, Eva MM, et al.
Publicado: (2020)

Feasibility of cognitive rehabilitation in patients with advanced multiple sclerosis: A pilot study
por: Prouskas, Stefanos E, et al.
Publicado: (2021)

Explaining the heterogeneity of functional connectivity findings in multiple sclerosis: An empirically informed modeling study
por: Tewarie, Prejaas, et al.
Publicado: (2018)

TREYESCAN: configuration of an eye tracking test for the measurement of compensatory eye movements in patients with visual field defects
por: Faraji, Yasmin, et al.
Publicado: (2023)

Histopathology-validated recommendations for cortical lesion imaging in multiple sclerosis
por: Bouman, Piet M, et al.
Publicado: (2020)

Increased functional sensorimotor network efficiency relates to disability in multiple sclerosis
por: Strik, Myrte, et al.
Publicado: (2020)

Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis
por: Grosskreutz, Julian, et al.
Publicado: (2006)

Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method
por: Popescu, Veronica, et al.
Publicado: (2016)

The role of diet in multiple sclerosis onset and course: results from a nationwide retrospective birth‐year cohort
por: Loonstra, Floor C., et al.
Publicado: (2023)

Adipokines in multiple sclerosis patients are related to clinical and radiological measures
por: Loonstra, Floor C., et al.
Publicado: (2022)

Neurophysiological MEG markers of cognitive impairment and performance validity in multiple sclerosis
por: Simon, Shira, et al.
Publicado: (2023)

Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis
por: Loonstra, Floor C., et al.
Publicado: (2022)

Serum neurofilament light chain predicts cognitive worsening in secondary progressive multiple sclerosis better than brain MRI measures
por: Gaetani, Lorenzo, et al.
Publicado: (2022)

Longitudinal Network Changes and Conversion to Cognitive Impairment in Multiple Sclerosis
por: Huiskamp, Marijn, et al.
Publicado: (2021)

Structure‐function relationships in the visual system in multiple sclerosis: an MEG and OCT study
por: Tewarie, Prejaas, et al.
Publicado: (2017)

A more unstable resting-state functional network in cognitively declining multiple sclerosis
por: Broeders, Tommy A. A., et al.
Publicado: (2022)

Network Collapse and Cognitive Impairment in Multiple Sclerosis
por: Schoonheim, Menno M., et al.
Publicado: (2015)

In-vivo imaging of meningeal inflammation in multiple sclerosis: Presence of evidence or evidence of presence?
por: Kilsdonk, Iris D, et al.
Publicado: (2017)

Blood and CSF Biomarker Dynamics in Multiple Sclerosis: Implications for Data Interpretation
por: Eikelenboom, M. J., et al.
Publicado: (2011)

Eye Movement Abnormalities in Amyotrophic Lateral Sclerosis
por: Guo, Xintong, et al.
Publicado: (2022)

Fetal Intraventricular Hemorrhage Due to Antiphospholipid Syndrome: A Case Report
por: Bouw, M. C., et al.
Publicado: (2021)

Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light
por: Wessels, Mark HJ, et al.
Publicado: (2023)

Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis
por: van Lierop, Zoë YGJ, et al.
Publicado: (2022)

The network collapse in multiple sclerosis: An overview of novel concepts to address disease dynamics
por: Schoonheim, Menno M., et al.
Publicado: (2022)

Longitudinal Development of Peripapillary Hyper‐Reflective Ovoid Masslike Structures Suggests a Novel Pathological Pathway in Multiple Sclerosis
por: Petzold, Axel, et al.
Publicado: (2020)

Efficient sensory cortical coding optimizes pursuit eye movements
por: Liu, Bing, et al.
Publicado: (2016)

The engagement of cortical areas preceding exogenous vergence eye movements
por: Wojtczak-Kwaśniewska, Monika, et al.
Publicado: (2018)

Functional brain network organization measured with magnetoencephalography predicts cognitive decline in multiple sclerosis
por: Nauta, Ilse M, et al.
Publicado: (2020)

Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis
por: Uitdehaag, Bernard M. J.
Publicado: (2018)

The sequence of structural, functional and cognitive changes in multiple sclerosis
por: Dekker, Iris, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vmjnqm6earahm2bhal86vtcqo2